Invesco Nasdaq Biotechnology Etf Last Dividend Paid
| IBBQ Etf | USD 23.20 0.19 0.83% |
Invesco Nasdaq Biotechnology fundamentals help investors to digest information that contributes to Invesco Nasdaq's financial success or failures. It also enables traders to predict the movement of Invesco Etf. The fundamental analysis module provides a way to measure Invesco Nasdaq's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Invesco Nasdaq etf.
Invesco |
Invesco Nasdaq Biotechnology ETF Last Dividend Paid Analysis
Invesco Nasdaq's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Invesco Nasdaq Biotechnology has a Last Dividend Paid of 0.0. This is 100.0% lower than that of the Invesco family and about the same as Health (which currently averages 0.0) category. The last dividend paid for all United States etfs is 100.0% higher than that of the company.
Invesco Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Invesco Nasdaq's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Invesco Nasdaq could also be used in its relative valuation, which is a method of valuing Invesco Nasdaq by comparing valuation metrics of similar companies.Invesco Nasdaq is currently under evaluation in last dividend paid as compared to similar ETFs.
Fund Asset Allocation for Invesco Nasdaq
The fund invests 99.97% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides Invesco Nasdaq's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Invesco Fundamentals
| Beta | 0.74 | |||
| Total Asset | 19.84 M | |||
| One Year Return | 21.60 % | |||
| Three Year Return | (0.70) % | |||
| Net Asset | 19.84 M | |||
| Equity Positions Weight | 99.97 % |
About Invesco Nasdaq Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Invesco Nasdaq Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invesco Nasdaq using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invesco Nasdaq Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Invesco Nasdaq
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Invesco Nasdaq position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Nasdaq will appreciate offsetting losses from the drop in the long position's value.Moving together with Invesco Etf
| 0.8 | XLV | Health Care Select | PairCorr |
| 0.85 | VHT | Vanguard Health Care | PairCorr |
| 0.98 | IBB | iShares Biotechnology ETF | PairCorr |
| 0.9 | XBI | SPDR SP Biotech | PairCorr |
Moving against Invesco Etf
| 0.48 | VO | Vanguard Mid Cap | PairCorr |
| 0.42 | VUG | Vanguard Growth Index | PairCorr |
| 0.41 | VB | Vanguard Small Cap | PairCorr |
| 0.4 | VTI | Vanguard Total Stock | PairCorr |
| 0.39 | SPY | SPDR SP 500 Aggressive Push | PairCorr |
The ability to find closely correlated positions to Invesco Nasdaq could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Invesco Nasdaq when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Invesco Nasdaq - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Invesco Nasdaq Biotechnology to buy it.
The correlation of Invesco Nasdaq is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Invesco Nasdaq moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Invesco Nasdaq Biote moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Invesco Nasdaq can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Invesco Nasdaq Piotroski F Score and Invesco Nasdaq Altman Z Score analysis. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
The market value of Invesco Nasdaq Biote is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Nasdaq's value that differs from its market value or its book value, called intrinsic value, which is Invesco Nasdaq's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Nasdaq's market value can be influenced by many factors that don't directly affect Invesco Nasdaq's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Nasdaq's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Nasdaq is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Nasdaq's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.